133 related articles for article (PubMed ID: 18848548)
1. Prevention of the cytopathic effect induced by Clostridium difficile Toxin B by active Rac1.
Halabi-Cabezon I; Huelsenbeck J; May M; Ladwein M; Rottner K; Just I; Genth H
FEBS Lett; 2008 Nov; 582(27):3751-6. PubMed ID: 18848548
[TBL] [Abstract][Full Text] [Related]
2. Cellular stability of Rho-GTPases glucosylated by Clostridium difficile toxin B.
Genth H; Huelsenbeck J; Hartmann B; Hofmann F; Just I; Gerhard R
FEBS Lett; 2006 Jun; 580(14):3565-9. PubMed ID: 16730714
[TBL] [Abstract][Full Text] [Related]
3. Serine-71 phosphorylation of Rac1/Cdc42 diminishes the pathogenic effect of Clostridium difficile toxin A.
Schoentaube J; Olling A; Tatge H; Just I; Gerhard R
Cell Microbiol; 2009 Dec; 11(12):1816-26. PubMed ID: 19709124
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cytokinesis by Clostridium difficile toxin B and cytotoxic necrotizing factors--reinforcing the critical role of RhoA in cytokinesis.
Huelsenbeck SC; May M; Schmidt G; Genth H
Cell Motil Cytoskeleton; 2009 Nov; 66(11):967-75. PubMed ID: 19504561
[TBL] [Abstract][Full Text] [Related]
5. Difference in the cytotoxic effects of toxin B from Clostridium difficile strain VPI 10463 and toxin B from variant Clostridium difficile strain 1470.
Huelsenbeck J; Dreger S; Gerhard R; Barth H; Just I; Genth H
Infect Immun; 2007 Feb; 75(2):801-9. PubMed ID: 17145947
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of the immediate early gene product RhoB by exoenzyme C3 from Clostridium limosum and toxin B from Clostridium difficile.
Huelsenbeck J; Dreger SC; Gerhard R; Fritz G; Just I; Genth H
Biochemistry; 2007 Apr; 46(16):4923-31. PubMed ID: 17397186
[TBL] [Abstract][Full Text] [Related]
7. Impact of amino acids 22-27 of Rho-subfamily GTPases on glucosylation by the large clostridial cytotoxins TcsL-1522, TcdB-1470 and TcdB-8864.
Müller S; von Eichel-Streiber C; Moos M
Eur J Biochem; 1999 Dec; 266(3):1073-80. PubMed ID: 10583404
[TBL] [Abstract][Full Text] [Related]
8. Difference in F-actin depolymerization induced by toxin B from the Clostridium difficile strain VPI 10463 and toxin B from the variant Clostridium difficile serotype F strain 1470.
May M; Wang T; Müller M; Genth H
Toxins (Basel); 2013 Jan; 5(1):106-19. PubMed ID: 23344455
[TBL] [Abstract][Full Text] [Related]
9. Listeria monocytogenes induced Rac1-dependent signal transduction in endothelial cells.
Schmeck B; Beermann W; van Laak V; Opitz B; Hocke AC; Meixenberger K; Eitel J; Chakraborty T; Schmidt G; Barth H; Suttorp N; Hippenstiel S
Biochem Pharmacol; 2006 Nov; 72(11):1367-74. PubMed ID: 16884694
[TBL] [Abstract][Full Text] [Related]
10. Protection from Clostridium difficile toxin B-catalysed Rac1/Cdc42 glucosylation by tauroursodeoxycholic acid-induced Rac1/Cdc42 phosphorylation.
Brandes V; Schelle I; Brinkmann S; Schulz F; Schwarz J; Gerhard R; Genth H
Biol Chem; 2012 Jan; 393(1-2):77-84. PubMed ID: 22628301
[TBL] [Abstract][Full Text] [Related]
11. Clostridium difficile toxins: more than mere inhibitors of Rho proteins.
Genth H; Dreger SC; Huelsenbeck J; Just I
Int J Biochem Cell Biol; 2008; 40(4):592-7. PubMed ID: 18289919
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of cyclooxygenase 2 expression by small GTPases Ras, Rac1, and RhoA.
Chang YW; Putzer K; Ren L; Kaboord B; Chance TW; Qoronfleh MW; Jakobi R
J Cell Biochem; 2005 Oct; 96(2):314-29. PubMed ID: 16088958
[TBL] [Abstract][Full Text] [Related]
13. Actin re-organization induced by Chlamydia trachomatis serovar D--evidence for a critical role of the effector protein CT166 targeting Rac.
Thalmann J; Janik K; May M; Sommer K; Ebeling J; Hofmann F; Genth H; Klos A
PLoS One; 2010 Mar; 5(3):e9887. PubMed ID: 20360858
[TBL] [Abstract][Full Text] [Related]
14. Rac1, RhoA, and Cdc42 participate in HeLa cell invasion by group B streptococcus.
Burnham CA; Shokoples SE; Tyrrell GJ
FEMS Microbiol Lett; 2007 Jul; 272(1):8-14. PubMed ID: 17517067
[TBL] [Abstract][Full Text] [Related]
15. R-Ras glucosylation and transient RhoA activation determine the cytopathic effect produced by toxin B variants from toxin A-negative strains of Clostridium difficile.
Chaves-Olarte E; Freer E; Parra A; Guzmán-Verri C; Moreno E; Thelestam M
J Biol Chem; 2003 Mar; 278(10):7956-63. PubMed ID: 12496290
[TBL] [Abstract][Full Text] [Related]
16. EhRho1, a RhoA-like GTPase of Entamoeba histolytica, is modified by clostridial glucosylating cytotoxins.
Majumder S; Schmidt G; Lohia A; Aktories K
Appl Environ Microbiol; 2006 Dec; 72(12):7842-8. PubMed ID: 17056697
[TBL] [Abstract][Full Text] [Related]
17. Glucosylation of Rho proteins by Clostridium difficile toxin B.
Just I; Selzer J; Wilm M; von Eichel-Streiber C; Mann M; Aktories K
Nature; 1995 Jun; 375(6531):500-3. PubMed ID: 7777059
[TBL] [Abstract][Full Text] [Related]
18. Human alpha-defensins inhibit Clostridium difficile toxin B.
Giesemann T; Guttenberg G; Aktories K
Gastroenterology; 2008 Jun; 134(7):2049-58. PubMed ID: 18435932
[TBL] [Abstract][Full Text] [Related]
19. Difference in the biological effects of Clostridium difficile toxin B in proliferating and non-proliferating cells.
Lica M; Schulz F; Schelle I; May M; Just I; Genth H
Naunyn Schmiedebergs Arch Pharmacol; 2011 Mar; 383(3):275-83. PubMed ID: 21212934
[TBL] [Abstract][Full Text] [Related]
20. Trans-10, cis-12 conjugated linoleic acid modulates phagocytic responses of canine peripheral blood polymorphonuclear neutrophilic leukocytes exposed to Clostridium difficile toxin B.
Kang JH; Lee GS; Jeung EB; Yang MP
Vet Immunol Immunopathol; 2009 Aug; 130(3-4):178-86. PubMed ID: 19269037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
